Tilray Brands (TLRY) EBIT Margin Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) EBIT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | 63,726.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 63,726.00 |
| Feb 28, 2026 | 39,629.00 |
| Nov 30, 2025 | 977.00 |
| Aug 31, 2025 | 1,928.00 |
| May 31, 2025 | -63,591.00 |
| Feb 28, 2025 | -36,546.00 |
| Nov 30, 2024 | 154.00 |
| Aug 31, 2024 | 114.00 |
| May 31, 2024 | 4,166.00 |
| Feb 29, 2024 | 78,527.00 |
| Nov 30, 2023 | 1,438.00 |
| Aug 31, 2023 | -560.00 |
| May 31, 2023 | 25,601.00 |
| Feb 28, 2023 | -81,696.00 |
| Nov 30, 2022 | -14.00 |
| Aug 31, 2022 | 2,746.00 |
| May 31, 2022 | -25,305.00 |
| Feb 28, 2022 | 751.00 |
| Nov 30, 2021 | -1,574.00 |
| Aug 31, 2021 | -3,407.00 |